Press Release - Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies
Novel screening tool provides first objective assessment for managing referral for device-assisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease
Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use of data from its wearable FDA-cleared watch, the Personal KinetiGraph® (PKG®), can provide an objective approach to identifying Parkinson’s Disease (PD) patients who may be candidates for device-assisted therapies (DAT) such as deep brain stimulation (DBS).
Read full press release here
Read published paper